Netherlands· NL-131cbb582eaa
Edoxaban Teva 30 mg, filmomhulde tabletten
A edoxaban product containing edoxabantosilaat 1-water, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Edoxaban is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AF03 (edoxaban), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Edoxaban · ATC B01AF03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of edoxaban costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Edoxaban · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- IT Italy$7.87
- CH Switzerland$6.81
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- EDOXABANTOSILAAT 1-WATER
- Manufacturer
- Teva Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- B01AF03
- ATC class
- Edoxaban
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132836
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
262 interactions on record for edoxaban.
Graded by severity as the source publishes them — 182 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Edoxaban · interactions on record
262 records
- 182 severe
- 80 moderate
Most severe, free to view
- RolapitantA04AD14severe
- EliglustatA16AX10severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Edoxaban in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELIANDAKrka, d.d., Novo mesto, Novo mesto
- SwedenEdoflusio 30 mg Filmdragerad tablettSandoz A/S
- SwitzerlandEdoxaban NOBEL 30 mg, FilmtablettenNOBEL Pharma Schweiz AG
- SpainEDOXABAN ALMUS 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAlmus Farmaceutica S.A.U.
- FinlandEdoxaban AvansorAvansor Pharma Oy
- PolandDeliandaKrka, d.d., Novo mesto
- IcelandEdoxaban AccordAccord Healthcare B.V.
- IrelandEdoxaban Accord 30 mg film-coated tabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Edoflusio, Edoxaban !@ctavis
- Belgium · Edoxaban Hcs, Edoxaban Sandoz
- Bulgaria · Edoflusio, Делианда
- Czechia · Delianda, Edoxaban +pharma
- Germany · Edoxaban 1 A Pharma, Edoxaban 123 Acurae Pharma
- Denmark · Arelzamio, Dijuga
- Estonia · Delianda, Edoflusio
- Spain · Edoxabán Almus, Edoxabán Cinfa
- Finland · Edoxaban Avansor, Edoxaban Krka
- France · Oblonela
- United Kingdom (Northern Ireland) · Edoxaban, Edoxaban Accord
- Greece · Delianda, Edoxaban Pharmapath
- Croatia · Cagluen, Delianda
- Hungary · Cagluen, Delianda
- Ireland · Edoxaban Accord, Edoxaban Krka
- Iceland · Edoxaban Accord, Edoxaban Krka
- Italy · Edoxaban Dr. Reddy’s, Edoxaban Hcs
- Liechtenstein · Lixiana, Roteas
- Lithuania · Delianda, Edoflusio
- Luxembourg · Oblonela
- Latvia · Delianda, Edoflusio
- Malta · Arelzamio, Dijuga
- Norway · Edoxaban Krka, Edoxaban Sandoz
- Poland · Delianda, Edoflusio
- Portugal · Edoxabano Bluepharma, Edoxabano Kern Pharma
- Romania · Cagluen, Delianda
- Sweden · Edoflusio, Edoxaban Avansor
- Slovenia · Delianda, Edoflusio
- Slovakia · Delianda, Edoxaban Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f30505b0-0aeb-4810-86fb-2ad475d65556 GET /v1/drugs/f30505b0-0aeb-4810-86fb-2ad475d65556?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132836_smpc_en.pdf",
"strength": null,
"atc_label": "Edoxaban",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132836",
"excipients": [
"CALCIUMCARBONAAT (E 170)",
"CROSCARMELLOSE NATRIUM (E 468)",
"HYPROLOSE (E 463)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE ROOD (E 172)",
"LACTOSE 1-WATER",
"MACROGOL 8000",
"MAGNESIUMSTEARAAT (E 470b)",
"TALK (E 553b)"
],
"substances": [
"EDOXABANTOSILAAT 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132836_piluk.pdf",
"authorised_at": "2025/02/14",
"procedure_number": "SE/H/2456/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "132836",
"additional_monitoring": "N"
}See everything about edoxaban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.